REJURANDUALEFFECTAMPOULEç¬èªæè¡DOTc-PDRNã«ã»ã©ãããé åã§ã¢ã³ããšã€ãžã³ã°ã«ïŒåŸã ã«èã®ããã¿ãããªãæ°ã«ãªãæ¹ã«ïŒãšãã¿ããã£ãŠã¿ãã¿ãããããªããã£ãšãããã¡ãã¡ä»äžããã«ããŠãããã¢ã³ãã«ã§ãïŒèŽ æ²¢æå...
ãã£ãšèŠãããããã¢ã€ãã REJURANÃçŸå®¹æ¶²
ååç»å | ååæ å ± | åèäŸ¡æ Œ | è©äŸ¡ | ã©ã³ãã³ã°IN | ç¹åŸŽ | ååãªã³ã¯ |
---|---|---|---|---|---|---|
REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã« | 8,250å |
| ãã©ã€ã¢ã«ãããã©ã³ãã³ã°ç¬¬59äœ | ãšãã£ãšãããã¯ã¹ãã£ãŒã§ããã£ããèãèŠã£ãŠæœ€ããããªäœ¿çšæã§ãð€ | 詳现ãèŠã | |
REJURAN ã¿ãŒã³ãªãŒããŒã¢ã³ãã« | 2,728å |
| ãã®ä»ã¢ã€ãããŠã©ã³ãã³ã°ç¬¬72äœ | èã®è¡šé¢ãã€ãããšããŠããŠå€æ¹ã®ããã¿ãæ°ã«ãªãã«ãããªããŸããïŒ | 詳现ãèŠã | |
REJURAN ã¢ã€ã¹ãã£ãŒããªãŒãã¡ã³ãã¢ã³ãã« | 3,850å |
| ãã£ã¡ããšããã¯ãªã¢ãªãã¯ã¹ãã£ã èãªãã¿ãããã£ãïŒïŒïŒïŒãã£ã±ãããšæããããã£ããä¿æ¹¿ | 詳现ãèŠã |
çŸå®¹æ¶²ã©ã³ãã³ã°
ååç»å | ååæ å ± | åèäŸ¡æ Œ | è©äŸ¡ | ã©ã³ãã³ã°IN | ç¹åŸŽ | ååãªã³ã¯ |
---|---|---|---|---|---|---|
SHISEIDO ã¢ã«ãã£ãã¥ãŒã³â¢ ãã¯ã©ã€ãžã³ã° ã»ã©ã | 9,900å(ç·šééšèª¿ã¹) |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬12äœ | ã¹ã«ã¹ã«ã£ãšäŒžã³ãŠãèã«ãªãããšã»ãã®ããã€æãæããŸãã åŸèã¯ãããã | 詳现ãèŠã | |
DECORTà ãªããœãŒã ã¢ããã³ã¹ãããªãã¢ã»ã©ã | 12,650å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬15äœ | ããããªã£ãããŸã£ãèãæãããã»ãããŠããããããªã€ã¡ãŒãžã§ããïŒ | 詳现ãèŠã | |
SK-II ãžã§ãããã£ã¯ã¹ ãªãŒã© ãšãã»ã³ã¹ | 20,900å(ç·šééšèª¿ã¹) |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬31äœ | ã·ãäºé²ã ãã§ãªãããã€ãäžããŠãããããã¡ãæŽããŠããã广ãïŒ | 詳现ãèŠã | |
Torriden ãã€ãã€ã³ ã»ã©ã | 2,420å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬43äœ | èã«ã®ãããšããã«ã¹ããšéŠŽæã¿ãŸãã銎æããšãã¿ã€ãããããµã©ãµã©ã«ãªãïŒ | 詳现ãèŠã | |
ã© ããã·ã¥ ã㌠ãšãã¡ã¯ã© ããŒã«ã±ã¢ ã»ã©ã | 5,280å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬72äœ | ããããšãã¿ã®ãããã¯ã¹ãã£ãŒã§ã䌞ã³è銎æã¿å ±ã«âã¹ãšã€ããªããã©ãã£ãšãä¿æ¹¿ããŠãããŸãïŒ | 詳现ãèŠã | |
REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã« | 8,250å |
| ãã©ã€ã¢ã«ãããã©ã³ãã³ã°ç¬¬59äœ | ãšãã£ãšãããã¯ã¹ãã£ãŒã§ããã£ããèãèŠã£ãŠæœ€ããããªäœ¿çšæã§ãð€ | 詳现ãèŠã | |
Anua ã¢ãŒã©ã€ã³é ž15 ã€ã³ãã³ã¹ã«ãŒãã³ã°ã»ã©ã |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬126äœ | 軜ãããªãã¯ã¹ãã£ãŒã§çŽ æ©ãèã«éŠŽæã¿ã最ããããªäœ¿ãå¿å°ã§ãâš | 詳现ãèŠã | ||
ESTEE LAUDER ã¢ããã³ã¹ ãã€ã ãªã㢠SMR ã³ã³ãã¬ãã¯ã¹ | 12,100å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬74äœ | ããªãã§ããããªã¹ã¹ã¡ã®çŸå®¹æ¶²ã§ãâš | 詳现ãèŠã | |
Anua ããŒã¯ã¹ãããã»ã©ã |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬33äœ | ä¿æ¹¿æåããã£ã·ããšé åãããŠããŠã ããäžæ¬ã§ããèããã£ãšããšããŸãâš | 詳现ãèŠã | ||
numbuzin 5çª çœçã°ã«ã¿ããªã³ïŒ£çŸå®¹æ¶² | 2,420å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬18äœ | ãšãã¿ã®ãããã¯ã¹ãã£ãŒãªã®ã«ããããããªãðð» | 詳现ãèŠã |
Mummmããã®äººæ°ã¯ãã³ã
ãã£ãšæ°ã«ãªã£ãŠãTheordinaryãCULTBEAUTYã«ãŠè³Œå ¥ããã°ãã䜿ã£ãŠã¿ãŸãããä»ã«ãè²ã è²·ã£ããã©ããšããããä»ããšãããããã¡ã°ãã®ãæ°ã«å ¥ãððâ VitaminCSuspension23%ïŒHASpheres2%ãµã¹ãã³...
ãã£ãšèŠã153
52
- 2019.10.27
䜿ã£ãŠéæ»ãªã確âŒïžå®å¿ã®å®åã¯ãªãŒã âšâšâšð¡AESTURAð¡ã¢ãããªã¢365ã¯ãªãŒã éåœã®ãã¯ã¿ãŒãºã¹ãã³ã±ã¢ãã©ã³ãã®ãšã¹ãã©ãåãã話é¡ã«ãªã£ãŠããã®ã§æ°ã«ãªã£ãŠè³Œå ¥â䜿ã£ãŠéæ»ãªã確å®ã³ã¹ã¡ã«âŒïžð¥³âšã¯ãªãŒã ã«çœãããããã®ã»ã©ããã«...
ãã£ãšèŠã95
2
- 2021.09.03
ã¢ã³ããšã€ãžã³ã°ã«âŒïžåŒŸåã¢ã³ãã«ð§¬ð§¬ð§¬åå远å ã§ããªãã®ã§ãããæïŒã€âïžâïžâïžâïžâïžð¡ã·ãã ãŒã«ð¡ã€ãããã³åŒŸåã¢ã³ãã«ãã¡ããpunbakiããã®åœ±é¿ã§è³Œå ¥ã也ç¥èãªäžã«è質ïŒè質ïŒãæããããŠããã¿ãããªã®ãªããæ°ã«ãªã£ãŠããã®ã§...
ãã£ãšèŠã92
3
- 2021.09.03
ã³ããçŠã«æé©ãªããðâšâšâšð¡ETUDEð¡ãã£ã¯ã·ã³ã°ãã£ã³ããžã³ãžã£ãŒãã«ã¯ãã£ãŒãããããã€ãã¢ãŒãŽã€ãå¿å°è»œãã®ã«å šç¶èœã¡ãªããèããªããè²å³ã坿ããç§ç2021幎äžåæãã¹ã³ã¹å ¥ã決å®ã®ãªããã§ãâŒïžãšã«ãã軜ãããã¿ããšå¯çããã®...
ãã£ãšèŠã88
3
- 2021.09.18
䜿ã£ãŠå³ãªã確ð¥ð¥ð¥éŒ»æ¯èãã¬ãð€ðð¡ã¯ãªãªãã£ãã¡ãŒã¹ãð¡ããŒãã¬ãŒã¶ãŒã¹ãŒããŒVC100ãã¹ã¯7æå ¥æºåž¯çšã¯ãªãªãã£ãã¡ãŒã¹ãã®ããã¯ã¯è²ã 詊ããŠãããã©ãªããšãªããã£ãããããã©ã¡ãããšãããšã«ã«ã«ã³æŽŸã§ããããããã¯1æäœ¿ã£ãŠå³å¹ãã...
ãã£ãšèŠã87
9
- 2022.04.12
ããããšããããŒã補è¬ðâ誰ðð¡ã¡ã³ãœã¬ãŒã¿ã ã¡ã©ãCCð¡ã¡ã©ãCCè¬çšãã¿éäžå¯Ÿçãã¬ãã¢ã çŸå®¹æ¶²ãã¬ãã¢ã ã«ããŒãžã§ã³ã¢ããããã¡ã©ãCCâŒïžæé žåãçã£ãŠãã¿ãã³Cç³»ã®ã¹ãã³ã±ã¢ã¯æã«å¿ ãåãå ¥ããããã«ããŠãã®ã§ããããåŸãªã®ã«ãã£ã...
ãã£ãšèŠã87
6
- 2021.09.03
åå詳现æ å ±REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã«
- ãã©ã³ãå
- REJURAN(ãªãžã¥ã©ã³)
- ã©ã³ãã³ã°IN
- å šäœã©ã³ãã³ã°å¹Žä»£å¥ã©ã³ãã³ã°è質å¥ã©ã³ãã³ã°
- 容éã»åèäŸ¡æ Œ
- 30ml: 8,250å
- åå説æ
- ãªãžã¥ã©ã³ã®ãªãªãžãã«PDRNãå ¥ã£ãŠããããªãã€çŸå®¹æ¶²ã c-PDRNâ»1 ããã€ã¢ã·ã³ã¢ããâ»2ããã¢ã«ãã³é žïŒ®ïœâ»2 ãã«ã³ãŸãŠæ ¹ãšãã¹â»3ãé åã è§è³ªå±€ãŸã§æœ€ããäžããèãªãºã ãæŽããâ»4ããšã§åŒŸåã®ããèæ¬æ¥ã®çŸãããžã ãªãžã¥ã©ã³æé«æè¡ã¹ããŒãšã€ãžã³ã°â»5äžèœçŸå®¹æ¶²ã â»1ãå æ°Žå解 : æŽèæå â»2ãé åç®çïŒä¿æ¹¿ â»3ãé åç®ç: æŽèæå â»4ãèããããã£ãŠããããããªç¶æ ã®ããš â»5ã幎霢ã«åãããã±ã¢ã®ããš
- ã¡ãŒã«ãŒå
- Pharma Research
- ã«ããŽãª
- ã¹ãã³ã±ã¢ã»åºç€åç²§å > çŸå®¹æ¶²
- æå
- ïŒ30mlïŒ æ°ŽãPEG-6ãã°ãªã»ãªã³ãã»ã€ãšãŠã€ãã€ããŽèãšãã¹ãBGãDPGããã€ã¢ã·ã³ã¢ããã1,2-ãããµã³ãžãªãŒã«ãã¢ããšãã©æ¶²æ±ãããŠãã³ã»ã³ã«è±ãšãã¹ãã«ã³ãŸãŠæ ¹ãšãã¹ãã¯ããã°ã¯æå®ãšãã¹ãããŒããã·ã¥ãã«ãŒããªãŒæå®ãšãã¹ãã«ã«ãããŒãã¹ã¯ã¯ã©ã³ãå æ°Žåè§£DNAãããµã³ã¿ã³ã¬ã ãæ°Žæ·»ã¬ã·ãã³ãã«ããªãªã«ã°ãªã³ãŒã«ããã¢ã«ãã³é žNaããšãã«ããã·ã«ã°ãªã»ãªã³ãããã·ã¬ã³ã°ãªã³ãŒã«ãããªãœã«ããŒã20ãã»ã©ããNPãã¢ããã·ã³ããã¬ãããŒã¹ãå°¿çŽ ããã³ãã¬ã³ã°ãªã³ãŒã«ãã¢ã«ããã³ãããµãããŒã«ãé ¢é žãã³ãã§ããŒã«ãã³ã¬ã¹ãããŒã«ãã»ãªã³ããªã¬ã€ã³é žãã©ãŠãªã«ã«ã«ããã³é žã€ããªã³ãã¢ã«ã®ã³é žNaããªã³é ž2Naãããªã¢ã¯ãªã«é žã°ãªã»ãªã«ããã«ã©ã³ããªã³é žK
ã³ã¡ã³ã